Bfsg LLC Acquires New Position in 4D Molecular Therapeutics,

Bfsg LLC acquired a new stake in shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,500 shares of the company’s stock, valued at approximately $30,000. A number of other institutional investors and hedge funds […]

Related Keywords

United States , David Kirn , Scott Bizily , Panagora Asset Management Inc , Mt Bank Corp , Nasdaq , T Bank Corp , Sg Americas Securities , D Molecular Therapeutics Inc , Jefferies Financial Group , Goldman Sachs Group , York Mellon Corp , Barclays , Affinity Wealth Management , Molecular Therapeutics , Free Report , Wealth Management , New York Mellon Corp , Asset Management , Financial Group , Molecular Therapeutics Trading Down , Get Free Report , Molecular Therapeutics Daily , 4d Molecular Therapeutics , Nasdaq Fdmt , Fdmt , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,